Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. — CFSMEATLAS
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine.
Magnus, Per, Gunnes, Nina, Tveito, Kari et al. · Vaccine · 2015 · DOI
Quick Summary
This large study of the Norwegian population during the 2009 flu pandemic found that people who caught the H1N1 influenza virus were more than twice as likely to develop ME/CFS afterward. However, people who received the pandemic flu vaccine did not show an increased risk of developing ME/CFS. This suggests that actually getting infected with the flu virus itself, rather than the vaccine, may trigger ME/CFS in some people.
Why It Matters
This study directly addresses a major concern among ME/CFS patients by examining whether the pandemic flu vaccine triggers CFS/ME. Using comprehensive national health data, it provides reassurance that the vaccine was not associated with increased CFS/ME risk while strengthening evidence that infectious triggers—specifically symptomatic influenza infection—may be involved in disease pathogenesis.
Observed Findings
Pandemic influenza A (H1N1) infection was associated with a 2-fold increased risk of CFS/ME diagnosis (adjusted HR 2.04, 95% CI: 1.78–2.33).
The adjuvanted pandemic flu vaccine showed no increased risk of CFS/ME (adjusted HR 0.97, 95% CI: 0.91–1.04).
The baseline incidence of CFS/ME was 2.08 cases per 100,000 person-months at risk in the Norwegian population.
Vaccinated individuals who were not infected did not show elevated CFS/ME rates compared to unvaccinated unexposed individuals.
Inferred Conclusions
Symptomatic influenza infection, rather than antigenic stimulation alone, may be the trigger for CFS/ME development in susceptible individuals.
The adjuvanted pandemic influenza vaccine does not increase CFS/ME risk and is not responsible for post-pandemic CFS/ME cases.
Infectious agents may play a key role in CFS/ME pathogenesis, supporting a model of post-infectious etiology for at least some cases.
Remaining Questions
Why does influenza infection trigger CFS/ME in some individuals but not others? What are the specific viral, immunological, or host factors that determine post-infectious CFS/ME development?
Does the association between influenza and CFS/ME apply to other respiratory infections or are other pathogens similarly implicated?
What This Study Does Not Prove
This study does not establish the mechanism by which influenza infection triggers CFS/ME, nor does it explain why only some infected individuals develop the condition. It cannot determine causation definitively—only association—and uses specialist health care diagnoses, which may underestimate true CFS/ME prevalence if many cases remain undiagnosed. The findings are specific to pandemic H1N1 and may not generalize to other influenza strains or non-influenza infections.